Clarivate Analytics: Cortellis Drug Discovery Intelligence - A New Drug Research Platform
Cortellis Drug Discovery Intelligence
A New Drug Research Platform
About Clarivate Analytics
Clarivate Analytics™ is a global leader in providing trusted insights and analytics to accelerate the pace of innovation. They have built some of the most trusted brands across the innovation lifecycle, including Web of Science™, Cortellis™, Derwent™, CompuMark™, MarkMonitor™ and Techstreet™.
About Cortellis
Cortellis™, a Clarivate Analytics solution, gives life to science by unlocking the hidden insights in data by curating broad and deep sources of intelligence to enable precise, actionable answers to specific questions across the R&D lifecycle— from discovery and clinical development through regulatory submission and commercialization. By supporting data-driven decisions, Cortellis helps pharmaceutical companies, biotech and medical device/diagnostic firms accelerate innovation.
Clarivate Analytics : Cortellis Drug Discovery Intelligence - a New Drug Research Platform
Clarivate Analytics ; a global leader in providing trusted insights and analytics to accelerate the pace of innovation, has introduced its next-generation pre-clinical drug research platform to support pharmaceutical companies’ drug discovery and pre-clinical efforts. Currently, the modern, user-friendly application has been updated and rebranded as Cortellis Drug Discovery Intelligence (CDDI).
About CDDI:
- A single source of continually-updated biology, chemistry and pharmacology data to support drug discovery and development.
- Allows researchers to more efficiently identify and validate drug targets, track their competitors and design effective experimental studies using scientific data on all drugs from first public disclosure.
- Comprised of data spanning 580,000+ drugs and biologics, 44,000+ genes and targets, 138,000+ experimental models, 2.4 million+ pharmacology data points, and more.
- Delivers analytics-ready data that enables more confident decision-making from the lab through the clinic to help avoid late-stage failures.